OK so I listened to the conference call. Great potential for collaboration with Edwards and perhaps on market for inpatient in 2010. Great potential for collaboration with Animas in closing the loop and have modified agreement to make sensor work with pump in foreign markets too, so one design will work everywhere. Back office is slammed there is so much sales increase right now. Increasing consensus among diabetes care community that CGM will become standard of care for insulin-treated patients, including the new market of insulin-treated type 2 diabetes. WOW, all sounds like a very bright future.